COLL - Collegium Pharmaceutical announces $2.75M settlement to resolve 27 opioid lawsuits

Collegium Pharmaceutical (NASDAQ:COLL) announces a settlement framework to resolve 27 pending opioid-related lawsuits brought against the firm by cities, counties, and other subdivisions in the U.S. The firm will pay up to $2.75M in exchange for the dismissal, with prejudice, of the lawsuits and a release from liability related to the dismissed cases. COLL clarifies that the settlement was reached to efficiently resolve the litigation and this was not an admission of wrongdoing.

For further details see:

Collegium Pharmaceutical announces $2.75M settlement to resolve 27 opioid lawsuits